SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
PROXYMED, INC..
- --------------------------------------------------------------------------------
(Exact name of issuer as specified in its charter)
2501 DAVIE ROAD, SUITE 230, FT. LAUDERDALE, FL 33317
- --------------------------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (954) 473-1001
---------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number
of shares outstanding:
1. Title of security $.001 par value, common stock
-----------------------------------------------------
2. Number of shares outstanding before the change 3,335,225
------------------------
3. Number of shares outstanding after the change 5,624,883
-------------------------
4. Effective date of change 5/13/96 and 5/23/96
----------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange,
distribution, stock split, reverse split, acquisition of
stock for treasury, etc.) public offering
---------------------------------------
Give brief description of transaction on may 13, 1996, ProxyMed completed a
-------------------------------------
public offering of 1,945,000 shares of common stock and on may 23, 1996,
- ------------------------------------------------------------------------
ProxyMed completed the over-allotment portion of such offering.
- ---------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
--------------------------------------------------
2. Name after change
-----------------------------------------------------
3. Effective date of charter amendment changing name
---------------------
4. Date of shareholder approval of change, if required
-------------------
Date: May 23, 1996 /s/HAROLD BLUE
------------------------------
Harold Blue, Chairman of the Board and Chief
Executive Officer
